# Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography

> **NCT03002480** · NA · WITHDRAWN · sponsor: **Children's Hospital Los Angeles**

## Conditions studied

- Hemophilia a with Inhibitors

## Interventions

- **OTHER:** Thromboelastography-Guided Treatment Regimen

## Key facts

- **NCT ID:** NCT03002480
- **Lead sponsor:** Children's Hospital Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never opened.
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002480, "Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03002480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*